These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26929268)

  • 41. Biochemical Characterization of β-Lactamases from Mycobacterium abscessus Complex and Genetic Environment of the β-Lactamase-Encoding Gene.
    Ramírez A; Ruggiero M; Aranaga C; Cataldi A; Gutkind G; de Waard JH; Araque M; Power P
    Microb Drug Resist; 2017 Apr; 23(3):294-300. PubMed ID: 27429159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Burgess DS; Hall RG
    Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
    Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
    Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The β-Lactams Strike Back: Ceftazidime-Avibactam.
    Zasowski EJ; Rybak JM; Rybak MJ
    Pharmacotherapy; 2015 Aug; 35(8):755-70. PubMed ID: 26289307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria.
    Edoo Z; Iannazzo L; Compain F; Li de la Sierra Gallay I; van Tilbeurgh H; Fonvielle M; Bouchet F; Le Run E; Mainardi JL; Arthur M; Ethève-Quelquejeu M; Hugonnet JE
    Chemistry; 2018 Jun; 24(32):8081-8086. PubMed ID: 29601108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental design and modelling approach to evaluate efficacy of β-lactam/β-lactamase inhibitor combinations.
    Sy SKB; Derendorf H
    Clin Microbiol Infect; 2018 Jul; 24(7):707-715. PubMed ID: 28760708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.
    Fattorini L; Scardaci G; Jin SH; Amicosante G; Franceschini N; Oratore A; Orefici G
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1760-4. PubMed ID: 1952844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.
    Levasseur P; Girard AM; Miossec C; Pace J; Coleman K
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1931-4. PubMed ID: 25583732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
    Miyasaka T; Kunishima H; Komatsu M; Tamai K; Mitsutake K; Kanemitsu K; Ohisa Y; Yanagisawa H; Kaku M
    Int J Antimicrob Agents; 2007 Sep; 30(3):255-8. PubMed ID: 17616451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic Efficacy of β-Lactam Combinations against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
    Bush K
    Int J Antimicrob Agents; 2015 Nov; 46(5):483-93. PubMed ID: 26498989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Killing of Escherichia coli by beta-lactams at different inocula.
    Tam VH; Ledesma KR; Chang KT; Wang TY; Quinn JP
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):166-71. PubMed ID: 19304437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104).
    Livermore DM; Mushtaq S; Barker K; Hope R; Warner M; Woodford N
    J Antimicrob Chemother; 2012 Jun; 67(6):1354-8. PubMed ID: 22441578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex.
    Shirata M; Yoshimoto Y; Marumo S; Tamai K; Fukui M
    Int J Infect Dis; 2020 Aug; 97():270-277. PubMed ID: 32526389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T405, a New Penem, Exhibits
    Rimal B; Batchelder HR; Story-Roller E; Panthi CM; Tabor C; Nuermberger EL; Townsend CA; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0053622. PubMed ID: 35638855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.